This page does not exist in your selected language. Your preference was saved and you will be notified once a page can be viewed in your language.
This page is also available in your prefered language. Switch to that version.
Albumin-Enabled Solutions
As a science-driven company and recognized leader of best-in-class albumin-enabled solutions, Albumedix enables the development and commercialisation of advanced therapies and next-generation biopharmaceuticals to the benefit of people worldwide.
Albumedix empowers excellence in your applications; combining high-quality, safe & consistent recombinant human albumin products, bespoke service packages tailor-made to enable your success, and innovative technologies.
Find high-quality animal and human-origin-free recombinant human albumins in the Recombumin® product portfolio.
Established in the UK in 1984, Albumedix, now a part of Sartorius, has supported its life science partners to deliver hundreds of millions of doses of clinical and marketed therapeutics, globally. The Recombumin® portfolio of recombinant human albumins includes the world’s only USP-NF compliant recombinant human albumin.
Recombumin® recombinant human albumin products are produced in a proprietary yeast strain (Saccharomyces cerevisiae) to ICHQ7 cGMP standards, formulated in the United Kingdom, and distributed worldwide to support our customers.
Ensuring stability during storage and transport was a critical task for Sartorius' customer Valneva in the development of the vaccine. Find out how Albumin solved the challenge.
View ProductsDownload Data Sheet
Not sure how to fully maximize the benefits of albumin to optimize performance, quality or consistency in your application? Our technical experts can increase your likelihood of technical and commercial success.
Find out More
Are you losing time navigating complex quality, technical or regulatory challenges? Sartorius is on hand with a range of bespoke compliance services, designed to empower success in your development. We'll get you to the market quickly and safely.
Sartorius’ drug delivery technology platform, Veltis®, uses engineered recombinant albumin to enhance albumin’s intrinsic characteristics for optimal therapeutic performance of your API.
They are manufactured at our site in Nottingham, UK from our proprietary Saccharomyces yeast strains, at ICH Q7 cGMP standards. As such it is the highest quality animal origin-free rAlb product commercially available.
Yes – As an example, Recombumin® is already used in two marketed vaccine products; Merck & Co’s MMR®-II and Proquad® childhood vaccine.
Please visit our Recombumin® product page for further product information or to submit an inquiry.
Sartorius Albumedix LimitedMabel StreetNOTTINGHAMNG2 3EDUNITED KINGDOM
Contact Phone Number | +44 (0) 115 955 3379
Email | bd.nottingham@sartorius.com
Sartorius offers sample-sized volumes for the Recombumin® portfolio to permit the evaluation of our recombinant human albumins in your specific application. Request sample volumes today using our eShop.
Please check out our careers page here on Sartorius.com where we list all the current opportunities that we have for you to join our team.
Complete our contact form, and one of our team members will contact you to discuss how Recombumin® could support your process. We have four decades of experience pioneering albumin-enabled solutions, and we are always keen to engage with new customers.
In recent years, Sartorius has been continuously making acquisitions, expanding its portfolio by new, complementary technologies.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.
Select your recombinant human albumin and benefit from our simplified shopping experience.